A statement released today by finnCap about Proteome Sciences PLC (LON:PRM) keeps the target price at 12.00GBX
- Updated: February 12, 2017
Yesterday Proteome Sciences PLC (LON:PRM) traded 2.24% higher at 0.00GBX. The company’s 50-day moving average is 5.14GBX and its 200-day moving average is 9.19GBX. The last stock close price is down -46.72% from the 200-day moving average, compared to the S&P 500 which has increased 0.06% over the same time. 876,236 shares of the stock were exchanged, up from an average trading volume of 403,700
Proteome Sciences PLC (LON:PRM) had its target price hold steady to 12.00GBX by finnCap in a report released 2/09/2017. The new target price indicates steady performance relative to the company's last stock close price.
Previously on 11/29/2016, finnCap reported about Proteome Sciences PLC (LON:PRM) held steady the target price at 12.00GBX. At the time, this indicated a possible upside of 1.13%.
See Chart Below
Proteome Sciences PLC has a 52 week low of 4.57GBX and a 52 week high of 23.94GBX The company’s market cap is currently 0 GBX.
In addition to finnCap reporting its target price, a total of 1 firm has issued a report on the stock. The consensus target price is 38.00GBX with 0 firms rating the stock a strong buy, 0 firms rating the stock a buy, 0 firms rating the stock a hold, 0 firms rating the stock a underperform, and finally 0 firms rating the stock a sell.
About Proteome Sciences PLC (LON:PRM)
Proteome Sciences plc is a protein biomarker company specializing in proteomics and peptidomics services and applications, and mass spectrometry (MS) protein analysis. The Company is engaged in biomarker research and development in applied proteomics and workflows using its techniques to detect and characterize differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic applications. It operates through the EU (the United Kingdom and Germany) and the United States geographic regions. Through the United Kingdom segment, it provides protein separation and MS capabilities for identification and analysis of post-translational modification of proteins in protein phosphorylation, image analysis and bioinformatics. Through the Germany segment, it provides protein profiling technologies, such as Tandem Mass Tags (TMT), which offers quantitation of proteins for the discovery of biomarkers. It has research agreements with various institutions in the United States.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.